» Articles » PMID: 30176346

Axin-2 Knockdown Promote Mitochondrial Biogenesis and Dopaminergic Neurogenesis by Regulating Wnt/β-catenin Signaling in Rat Model of Parkinson's Disease

Overview
Date 2018 Sep 4
PMID 30176346
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Wnts and the components of Wnt/β-catenin signaling are widely expressed in midbrain and required to control the fate specification of dopaminergic (DAergic) neurons, a neuronal population that specifically degenerate in Parkinson's disease (PD). Accumulating evidence suggest that mitochondrial dysfunction plays a key role in pathogenesis of PD. Axin-2, a negative regulator of Wnt/β-catenin signaling affects mitochondrial biogenesis and death/birth of new DAergic neurons is not fully explored. We investigated the functional role of Axin-2/Wnt/β-catenin signaling in mitochondrial biogenesis and DAergic neurogenesis in 6-hydroxydopamine (6-OHDA) induced rat model of PD-like phenotypes. We demonstrate that single unilateral injection of 6-OHDA into the medial forebrain bundle (MFB) potentially dysregulates Wnt/β-catenin signaling in substantia nigra pars compacta (SNpc). We used shRNA lentiviruses to genetically knockdown Axin-2 to up-regulate Wnt/β-catenin signaling in SNpc in parkinsonian rats. Genetic knockdown of Axin-2 up-regulates Wnt/β-catenin signaling by destabilizing the β-catenin degradation complex in SNpc in parkinsonian rats. Axin-2 shRNA mediated activation of Wnt/β-catenin signaling improved behavioural functions and protected the nigral DAergic neurons by increasing mitochondrial functionality in parkinsonian rats. Axin-2 shRNA treatment reduced apoptotic signaling, autophagy and ROS generation and improved mitochondrial membrane potential which promotes mitochondrial biogenesis in SNpc in parkinsonian rats. Interestingly, Axin-2 shRNA-mediated up-regulation of Wnt/β-catenin signaling enhanced net DAergic neurogenesis by regulating proneural genes (Nurr-1, Pitx-3, Ngn-2, and NeuroD1) and mitochondrial biogenesis in SNpc in parkinsonian rats. Therefore, our data suggest that pharmacological/genetic manipulation of Wnt signaling that enhances the endogenous regenerative capacity of DAergic neurons may have implication for regenerative approaches in PD.

Citing Articles

Wnt/β-catenin signaling pathway: proteins' roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosis.

Wang X, Qu Z, Zhao S, Luo L, Yan L Mol Med. 2024; 30(1):193.

PMID: 39468464 PMC: 11520425. DOI: 10.1186/s10020-024-00957-x.


Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative Diseases.

Faraji N, Ebadpour N, Abavisani M, Gorji A Mol Neurobiol. 2024; 62(3):3630-3652.

PMID: 39313658 PMC: 11790780. DOI: 10.1007/s12035-024-04462-4.


ARMC10 regulates mitochondrial dynamics and affects mitochondrial function via the Wnt/β-catenin signalling pathway involved in ischaemic stroke.

Huang Y, Zhang Z, Xu Y, Peng Y, Xu R, Luan Y J Cell Mol Med. 2024; 28(12):e18449.

PMID: 38924214 PMC: 11196997. DOI: 10.1111/jcmm.18449.


Maintaining moderate levels of hypochlorous acid promotes neural stem cell proliferation and differentiation in the recovery phase of stroke.

Huang L, Zhang Y, Chen J, Fan H, Wang W, Wang B Neural Regen Res. 2024; 20(3):845-857.

PMID: 38886957 PMC: 11433893. DOI: 10.4103/1673-5374.392889.


Mitochondrial metabolism in neural stem cells and implications for neurodevelopmental and neurodegenerative diseases.

Garone C, De Giorgio F, Carli S J Transl Med. 2024; 22(1):238.

PMID: 38438847 PMC: 10910780. DOI: 10.1186/s12967-024-05041-w.